BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3470579)

  • 21. In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia.
    Colovic M; Sefer D; Bogdanovic A; Suvajdzic N; Jankovic G; Atkinson HD; Milenkovic P
    Cancer Lett; 2003 Jun; 195(2):153-9. PubMed ID: 12767523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.
    Carlo-Stella C; Regazzi E; Garau D; Mangoni L; Rizzo MT; Bonati A; Dotti G; Almici C; Rizzoli V
    Br J Haematol; 1996 Jun; 93(3):551-7. PubMed ID: 8652372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane receptors for interleukin 2 on hematopoietic precursors in chronic myeloid leukemia.
    Visani G; Delwel R; Touw I; Bot F; Löwenberg B
    Blood; 1987 Apr; 69(4):1182-7. PubMed ID: 3103714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).
    Marley SB; Lewis JL; Scott MA; Goldman JM; Gordon MY
    Br J Haematol; 1996 Nov; 95(2):299-305. PubMed ID: 8904885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.
    Luna-Bautista F; Sánchez-Valle E; Ayala-Sánchez M; Morales-Polanco M; Meillon-García L; Benítez-Bribiesca L; Mayani H
    Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells.
    Su RJ; Zhang XB; Li K; Yang M; Li CK; Fok TF; James AE; Pong H; Yuen PM
    Br J Haematol; 2002 Jun; 117(3):735-46. PubMed ID: 12028051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T; Korycka A
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
    Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
    Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
    Korycka A; Robak T
    Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells.
    Zauli G; Visani G; Vitale M; Gibellini D; Bertolaso L; Capitani S
    Br J Haematol; 1995 Jun; 90(2):274-82. PubMed ID: 7540854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of H-7 and staurosporine on proliferation and self-renewal of acute myeloid leukemia progenitors.
    Laredo J; Demur C; Muller C; Saivin S; Cassar G; Bousquet C; Dastugue N; Jaffrézou JP; Colombies P; Laurent G
    Leukemia; 1993 Jun; 7(6):813-20. PubMed ID: 8501977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow.
    Delwel R; van Gurp R; Bot F; Touw I; Löwenberg B
    Leukemia; 1988 Dec; 2(12):814-9. PubMed ID: 3199876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.
    Eaves AC; Cashman JD; Gaboury LA; Kalousek DK; Eaves CJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5306-10. PubMed ID: 3460093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.